In details, we have previously demonstrated, that the HDACi vorinostat in combination with capecitabine produces a synergistic antitumor effects by up-regulating, in vitro and in vivo, in colorectal cancer cells but not in ex vivo treated peripheral blood lymphocytes, the mRNA and protein expression of TP [18]. The gene discussed is TYMP; the disease is colorectal cancer.